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Abstract:   
 Cancer is a rapidly growing fatal disease and with the various thiazole 
compounds being scientifically generated, possible treatment options can be 
implemented. Proper synthesis of 2,3-dimethoxy-1,4-benzoquinone allows for a variety 
of compounds to be made with further treatment of alkylthio reagents. Both 
thioacetamide and thiobenzamide are used to react with 2,3-dimethoxy-1,4-
benzoquinone in order to build a library of thiazoles. Final compounds can be tested for 
the ability to inhibit recombinant enzyme activity and the capability to kill tumor cells. A 
basic oxidation procedure along with nucleophilic attack was used to create target 
products.  
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Introduction: 
 
 Cancer is a worldwide epidemic that is quickly growing and spreading. Special 
attention must be put on cancer research in order to put up an honest fight against its 
fatal qualities. With over one hundred different types, cancer is the disease 
characterized by exaggerated cell growth.1 According to the World Cancer Research 
Fund International, in the year 2008, over 12.7 million new cases of cancer were 
diagnosed.2 The most common type being lung cancer for men and breast cancer for 
women. The majority of cancers have a very low survival rate and are highly dependent 
on early detection and treatment. Andrei Gartel and his group of researchers found that 
synthesized thiazole antibiotics efficiently inhibited the growth and induced potent 
apoptosis in human cancer cell lines of different origin.3 There seems to be a link 
between thiazole compounds and cancer treatment and with this thought in mind, this 
project is dedicated to the building of different thiazole compounds in order to find a 
similar inhibition of cancer cells. 
 Various chemists have devoted years of research to tap into this disease and 
figure out how it can be treated. Hans-René Bjørsvik and his team have tested 
switchable oxidation processes leading to various pharmaceutical intermediates.4 Their 
approach was to design and implement a new process for the preparation of methyl- 
and methoxy- substituted arenes which would be the building blocks for the 
antioxidants, pharmaceutical chemicals, and compounds used in nutraceuticals. Using 
the most activated substrate, 1,2,3-trimethoxy-5-methylbenzene, Bjørsvik and his team 
achieved the highest yield.3 In our experiment, we employed a similar procedure for the 
synthesis of 2,3-dimethoxy-5-methyl-1,4-benzoquinone, but instead use 1,2,3-
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trimethoxybenzene (1) as our starting material. Yan-Ping Shi worked with synthesizing 
flavonoids and from his work we studied the procedure, which similarly to Bjørsvik, used 
(1) as a substrate to make 2, 3-dimethoxy-1,4-benzoquinone (2)1. However, our 
reaction conditions will be different to achieve this compound. 
 
  
 
Figure 1. Experimental Design. 
  
 Following the work of Alan R. Katritzky and Wei-Qiang Fan on quinones 
containing fused ring systems, we used a similar procedure designed to synthesize 2-
methylnaphtho[2,3-d]thiazole-4,9-dione from the thioacetamide and 2-mercapto-3-
amino-1,4-naphthoquinone.5 However, our project had some notable differences. 
Firstly, since our reaction would not produce HCl, thus we would not need to use 4-
diazabicyclo [2.2.2]octane (DABCO) as a base or dimethyl sulfoxide (DMSO) as a 
solvent. Instead, methanol was used as a solvent since the reaction will generate it. 
Secondly, our backbone compound, 2,3-dimethoxy-1,4-benzoquinone was treated with 
a thioalkylamide (3) in hopes of reaching our goal of synthesizing 2-
alkylbenzo[d]thiazole-4,7-dione (4). 
 The goal of this project is to design, synthesize and evaluate 2-alkyl-5, 6-
bis(alkylthio)benzo[d]thiazole-4,7-dione derivatives as thioesterase (TE1) inhibitors to 
block TE1 activity or as cyclin-dependant kinase (CDK) inhibitors. The compounds will 
be synthesized by building a 2-alkylbenzo[d]thiazole-4, 7-dione library of compounds 
MeOH 
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which can then be treated with alkylthiol reagents and be converted into multiple final 
targets for a quick library of compounds. These compounds will then be tested to (i) 
inhibit recombinant enzyme activity, (ii) inhibit cellular fatty acid synthesis or CDK 
inhibition, and (iii) specifically kill tumor cells. 
Methods: 
Experimental procedures were completed at Southern Adventist University using 
standard laboratory glassware from ChemGlass or Kimble Kontes, and various reagents 
obtained commercially from Alfa Aesar, Sigma-Aldrich, Acros, Anal Tech and Fisher. All 
the reactions were carried out using CG-1994-Chemglass Optimag Magnetic Hot Plate 
Stirrers with Safety Controls with CG-1991-P Pie Blocks, Reaction Blocks, and Safety 
Holders. All solvents were evaporated using a Wilmad Lab Glass rotovap WG-EV311 or 
Buchi RE 111 rotovapor. When needed, products were run on a Jeol 400 mHz NMR 
Spectrometer used at the University of Tennessee Chattanooga. 
Reaction 1 
Synthesis of 2, 3-Dimethoxy-[1, 4]benzoquinone (2). A solution of 1,2,3-
trimethoxybenzene (3.20 g, 19 mmol) and acetic acid (19 mL) was added to a three 
neck round bottom flask and stirred using a reflux condenser. A bubbler was set up 
using nitrogen gas and mineral oil to keep an open system for the exothermic reaction. 
Then, p-toluene sulfonic acid monohydrate (0.362 g, 1.9 mmol) and hydrogen peroxide 
(30%, 3.24 mL, 38 mmol) were added to flask. The reaction mixture was stirred and 
heated at 75°C for 30 minutes and monitored using thin-layer chromatography (TLC) by 
checking the consumption of starting material and the formation of product 2. Once the 
reaction was verified it was then cooled to 0°C. Nitric acid (90%, 0.41 mL, 8.7 mmol) 
was added dropwise. The cold reaction mixture was poured into water and extracted 
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with dichloromethane. The organic layers were combined and washed with water to 
remove residues of acetic acid, dried over anhydrous sodium sulfate and filtered. 
Finally, the solvent was evaporated under reduced pressure to achieve the crude as 
dark red oil. 
Purification. The crude product was dissolved in boiling hexane and filtered. 
Solvent was removed under reduced pressure to provide the purer compound 2. 
Column chromatography was used with dry packing to further purify the product. A 20:1 
ratio of silica gel versus crude mass was calculated for the column. Silica gel was mixed 
with dichloromethane and poured into the column.  A 2:1 ratio of silica gel versus crude 
mass was calculated for the dry pack. The gel was dissolved in the least polar solvent, 
hexane, mixed with crude and evaporated under reduced pressure to obtain powder to 
pack in column. The solvent system used was hexane:ethyl acetate, obtaining five 25  
mL fractions of 9:1, 8:2, and 7:3 ratios, respectively. This solvent system was used 
throughout all subsequent reactions. Selected pool containing product evaporated 
under reduced pressure to obtain a maroon solid (0.250 g, 7.81% yield). 
Reaction 2 
Synthesis of 2-methylbenzo[d]thiazole-4,7-dione (4a, R=Me). Once product 2 
(0.07 g, 0.42 mmol) was synthesized, it was treated with thioacetamide (0.086 g, 0.63 
mmol) using methanol (1 mL) as the solvent. The mixture was stirred using Pie blocks 
and the reaction went to completion. The reaction was monitored using TLC. The 
mixture was also further purified by means of column chromatography. Fifteen fractions 
of 8 mL each were obtained from mixture and the selected pool was evaporated under 
reduced pressure (0.034 g, 63.89% yield). 
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Reaction 3 
Synthesis of 2-phenyl-4,7-benzothiazoledine (4b, R=Ph). Using product 2 
(0.05 g, 0.30 mmol), the reaction was run using thiobenzamide (0.045 g, 0.33 mmol) 
and methanol (1 mL) as a solvent. The mixture was stirred using Pie blocks and the 
reaction went to completion. The reaction was monitored using TLC and was further 
purified by means of column chromatography. Twenty fractions of 5 mL each were 
obtained from mixture and the selected pool was evaporated under reduced pressure to 
obtain yellow solid (0.067 g, 92.5% yield).  
Reaction 4 
 Treatment of 2-alkylbenzo[d]thiazole-4, 7-dione using N-Acetylcysteamine. 
2-phenyl-4, 7-benzothiazoledine (0.067 g, 0.278 mmol) (4b) was dissolved in methanol 
(0.70 mL) and treated with N-acetylcysteamine (31 µL, 0.278 mmol). The reaction 
mixture was allowed to stir for two days at a constant temperature of 60°C. Methanol 
was evaporated under reduced pressure and later purified by column chromatography.7 
HNMR indicated that starting material was recovered. Another attempt to synthesize the 
desired targets is underway. 
 
 
 
 
 
 
 
  
Results: 
Reaction 1 
Figure 2. NMR estimation for product 
 
Figure 3. NMR for product 2. 
 
 
 
 
2.  
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Reaction 2 
Figure 4. NMR estimation for product 
 
Figure 5. NMR results for product
 
 
 
 
4 with R=Me.  
 
 4 with R=Me. 
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Reaction 3 
Figure 6. NMR estimation for product
 
Figure 7. NMR data received for purified sample of product 
 
 
 
 4 with R=Ph. 
 
4 with R=Ph. 
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Discussion: 
 Various attempts were made in the refining of the methods for reaction 1. Pie 
blocks were implemented to control the temperature of the reaction but after many tries, 
an open bubbler system was found to achieve better results as the exothermic activity 
could be monitored via bubbling the mineral oil. Dicholomethane was used as the final 
solvent during the evaporation process to adhere cleaner NMR readings. The lower 
yield shown in Reaction 1 is a result of maintaining inaccurate temperatures due to the 
lack of a Pie block system, possibly causing starting material to have been burnt. 
However, NMR results show a very pure product was obtained therefore the lower yield 
is more readily accepted.  
 Reaction 3 shows successful product purity and yield. The products purity relied 
heavily on the fact that pure product from Reaction 1 was used and had no impurities. 
Both reactions were also purified using column chromatography. Successful production 
of this product allows for further nucleophilic attack on the quinone side of the molecule. 
The NMR estimation is assuming that the hydrogen atoms on the quinone side are the 
same, but they are not because the molecule is not symmetrical. Another reason for 
purity would be that this was a short reaction and the proper conditions were 
implemented for optimal results.  
 The results of Reaction 4 were verified by means of NMR and resulted in 
recovery of starting material. This means either the reaction did not go to completion, or 
simply did not work. Further oxidation reactions might have to be implemented to obtain 
proper product.  
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Conclusions: 
 According to Figure 1, the synthesis of two derivatives (R=Ph and Me) have been 
achieved in this research project. Larger scale syntheses of either product will be 
necessary to continue the building of the thiazole products. In order to continue this 
research, further nucleophilic attack would have to be completed on either product, 
resulting in the final product 5. With successful methods now developed for products 2, 
and 4a with R=Me and with 4b with R=Ph, continuation of this project would expand the 
library of viable heterocyclic compounds to test for cancer. Various alkylthio 
nucleophiles can be used to make different versions of product 5 and once these 
products have been properly synthesized; further testing can be done to assess their 
chances against fighting cancer.  
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